Back to news overview

eTheRNA receives € 1 million from VLAIO for cancer research

eTheRNA Immunotherapies, a clinical-stage company and VUB spin-off, announces it has been awarded a € 1 million industrial R&D Projects Grant by Flanders Innovation & Entrepreneurship (VLAIO).

You can read the full article here

Source: De Tijd - September 25